Poliomyelitis
📧 Sign up to get email alerts when something new happens for Poliomyelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults [Phase 1]
Phase 1 safety and reactogenicity study comparing a single dose of monovalent high-dose IPV type 2 vaccine (m-IPV2 HD) to standard trivalent…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Diarrhea and Bivalent Oral Polio Vaccine Immunity [NA]
A completed trial assessed seroimmunity to poliovirus and incidence of diarrhea following administration of the bivalent oral polio vaccine.
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) [Phase 3]
Phase 3 trial of an investigational V441-001 vaccine in healthy infants in Taiwan has completed, targeting diphtheria, tetanus, pertussis, h…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth [Phase 3]
Phase 3 trial of the DTaP-IPV-HepB-PRP-T pentavalent vaccine in Indian infants completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine [Phase 3]
A Phase 3 trial sponsored by the CDC evaluating the immunogenicity of an intramuscular inactivated poliovirus vaccine has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine [Phase 4]
Completed Phase 4 trial assessing safety and immunogenicity of one or two doses of inactivated poliovirus vaccine in Latin American infants …
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life [Phase 2]
Phase 2 safety study of a monovalent high-dose inactivated poliovirus type 2 vaccine (m-IPV2 HD) in infants has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3 [NA]
A clinical trial comparing short-interval mOPV1 with standard-interval mOPV1 and bOPV (types 1 and 3) has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age [Phase 3]
A Phase 3 trial evaluating the DTap-IPV vaccine as the fifth dose in children aged 4 to 6 years, comparing it with DAPTACEL and IPOL; result…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216
Follow-up study reports antibody responses to hepatitis B, acellular pertussis toxin, and inactivated poliovirus antigens 1 month after the …
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan [Phase 4]
A Phase 4 study of IMOVAX POLIO booster vaccine in pre-school children in Japan has completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis [Phase 2]
Phase 2 trial of a combined tetanus, diphtheria, acellular pertussis, and inactivated poliomyelitis vaccine sponsored by Sanofi Pasteur has …
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects [Phase 2]
Phase 2 trial comparing intradermal versus intramuscular polio vaccine booster in HIV-infected subjects; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine [Phase 4]
A Phase 4 trial comparing sequential vaccination with the inactivated poliovirus vaccine (IPV) followed by oral poliovirus vaccine (OPV) ver…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants [Phase 3]
Phase 3 trial comparing the safety and immunogenicity of Pediacel versus Infanrix IPV+Hib (Penta) given in a 3-dose schedule in infants; the…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® [Phase 3]
Phase 3 trial comparing booster vaccination with Pediacel versus Infanrix Hexa when co-administered with Prevenar in healthy infants has com…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants [Phase 2]
Phase 2 trial of GSK2202083A vaccine in healthy infants completed; multiple conditions tested including tetanus, hepatitis B, Hib, polio, ac…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial assessing safety and immunogenicity of booster doses for new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (GSK217744) in chi…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants [Phase 3]
A Phase 3 trial assessed the booster effect of the DTaP-IPV-HepB-PRP-T vaccine (Infanrix Hexa) and Prevenar in healthy infants; results were…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial update on safety and immunogenicity of new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (DTPa-HBV-IPV/Hib, GSK217744).
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 lot-consistency study of the DTaP-IPV-HB-PRP~T vaccine administered at 2-4-6 months in healthy infants has completed; results were…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants [Phase 3]
Phase 3 study evaluating the DTaP-IPV-Hep B-PRP-T vaccine given with Prevenar and Rotarix in healthy Latin American infants; results were po…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers [Phase 3]
Phase 3 safety trial of Infanrix-IPV+Hib vaccine in healthy Vietnamese toddlers completed with results posted
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV [Phase 3]
A Phase 3 trial comparing the DTaP-IPV-Hep B-PRP-T combined vaccine to CombAct-HIB given with Engerix B Paediatric and OPV; results were pos…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants [Phase 3]
Phase 3 study assessing the immunogenicity and safety of a booster dose of the DTaP-IPV-HB-PRP~T combined vaccine in healthy Turkish infants…